JUDY CAO: Open Payments
NPI 1003288721 · SILVER SPRING, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 15 payments from 7 companies in 2025. Trend: 2023 $352 · 2024 $474 · 2025 $329
Food & beverage: $284Education: $45
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $77 |
| Amgen Inc. | 4 | $72 |
| Lilly USA, LLC | 2 | $62 |
| Medtronic, Inc. | 1 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Abbott Laboratories | 1 | $19 |
Products named: Veozah, OTEZLA, MINIMED 780G, VOQUEZNA, FREESTYLE LIBRE 3, FARXIGA, MOUNJARO, BREZTRI.
Industry payments across MD — which companies pay providers there.
